The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Low Grade Chronic Inflammation in Women with Polycystic Ovarian Syndrome
Abstract
Low grade chronic inflammation as reflected by increased C-reactive protein (CRP) concentrations independently predicts those at risk for coronary heart disease (CHD) and type 2 diabetes. Women with polycystic ovarian syndrome (PCOS) are insulin resistant and have increased risk for CHD and type 2 diabetes, but currently there are no data on markers of inflammation in women with PCOS. Seventeen women with PCOS (defined on the basis of elevated testosterone and oligomenorrhea) and 15 healthy women matched as a group for body mass index were recruited. Measurement of CRP concentrations was made using a highly sensitive assay. Insulin resistance was assessed using the hyperinsulinemic euglycemic clamp technique. The women with PCOS had significantly elevated CRP concentrations relative to controls (geometric means, 2.12 and 0.67 mg/L, respectively; P = 0.016). Log CRP correlated with body mass index in both PCOS and controls (r = 0.58; P < 0.05 and r = 0.78; P < 0.01, respectively) and inversely with insulin sensitivity (r = -0.57; P < 0.05 and r = -0.69; P < 0.01). Total testosterone did not correlate with log CRP in either group. On adjustment for body mass index and age, there remained a significant difference in log CRP between PCOS and controls (t = 2.13; P < 0.05). On further adjustment for insulin sensitivity, log CRP was no longer significantly different between groups (t = 1.51; P = 0.14). We conclude that women with PCOS have significantly increased CRP concentrations relative to women with normal menstrual rhythm and normal androgen levels. We propose low grade chronic inflammation as a novel mechanism contributing to increased risk of CHD and type 2 diabetes in these women.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CRP and PAI-1 are reliable markers of inflammation and sensitive predictors of cardiovascular morbidity.57”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Yudkin, J. S., Stehouwer, C. D. A., Emeis, J. J., & Coppack, S. W. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.4.972 · Cited by 2,465
Chronic Subclinical Inflammation as Part of the Insulin Resistance Syndrome
Festa, A., D’Agostino, R., Howard, G., Mykkänen, L., Tracy, R. P., & Haffner, S. M. (2000) · Circulation · doi:10.1161/01.cir.102.1.42 · Cited by 2,366
Köenig, W., Sund, M., Fröhlich, M., Fischer, H.-G., Löwel, H., Döring, A., Hutchinson, W. L., & Pepys, M. B. (1999) · Circulation · doi:10.1161/01.cir.99.2.237 · Cited by 1,952
Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells
Pasceri, V., Willerson, J. T., & Yeh, E. T. H. (2000) · Circulation · doi:10.1161/01.cir.102.18.2165 · Cited by 1,944
Legro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743
Ridker, P. M., Buring, J. E., Shih, J., Matias, M., & Hennekens, C. H. (1998) · Circulation · doi:10.1161/01.cir.98.8.731 · Cited by 1,642
Production of C-reactive protein and risk of coronary events in stable and unstable angina
Haverkate, E., Thompson, S. G., Pyke, S., Gallimore, J. R., & Mark B Pepys Group (1997) · The Lancet · doi:10.1016/s0140-6736(96)07591-5 · Cited by 1,511
Flagged first, then by citations
Cited by
Sorted by citations
Inflammation in obesity, diabetes, and related disorders
Rohm, T. V., Meier, D. T., Olefsky, J. M., & Donath, M. Y. (2022) · Immunity · doi:10.1016/j.immuni.2021.12.013 · Cited by 2,066
Norman, R. J., Dewailly, D., Legro, R. S., & Hickey, T. E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61345-2 · Cited by 1,360
Chronic Low Grade Inflammation in Pathogenesis of PCOS
Rudnicka, E., Suchta, K., Grymowicz, M., Calik-Ksepka, A., Smolarczyk, K., Duszewska, A. M., Smolarczyk, R., & Meczekalski, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073789 · Cited by 680
Maternal Obesity Is Associated with Dysregulation of Metabolic, Vascular, and Inflammatory Pathways
Ramsay, J. E., Ferrell, W. R., Crawford, L., Wallace, A. M., Greer, I. A., & Sattar, N. A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020311 · Cited by 659
Diabetes mellitus and periodontal disease
Mealey, B. L., & Ocampo, G. L. (2007) · Periodontology 2000 · doi:10.1111/j.1600-0757.2006.00193.x · Cited by 579
Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis
Escobar-Morreale, H. F., Luque‐Ramírez, M., & González, F. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.11.036 · Cited by 538
Polycystic ovary syndrome and cardiovascular disease: a premature association?
Legro, R. S. (2003) · Endocrine Reviews · doi:10.1210/er.2003-0004 · Cited by 466
González, F., Rote, N. S., Minium, J., & Kirwan, J. P. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1696 · Cited by 459
The Molecular-Genetic Basis of Functional Hyperandrogenism and the Polycystic Ovary Syndrome
Escobar-Morreale, H. F., Luque‐Ramírez, M., & Millán, J. L. S. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0004 · Cited by 426
Macrophage contributions to ovarian function
Wu, R. (2004) · Human Reproduction Update · doi:10.1093/humupd/dmh011 · Cited by 387
What Does Minor Elevation of C-Reactive Protein Signify?
Kushner, I., Rzewnicki, D., & Samols, D. R. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.06.057 · Cited by 372
Maas, A. H. E. M., Rosano, G. M. C., Cífková, R., Chieffo, A., van Dijken, D., Hamoda, H., Kunadian, V., Laan, E. T. M., Lambrinoudaki, I. V., Maclaran, K., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa1044 · Cited by 382
Boulman, N., Levy, Y., Leiba, R., Shachar, S. S., Linn, R., Zinder, O., & Blumenfeld, Z. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031096 · Cited by 332
Is PCOS an inflammatory process?
Duleba, A. J., & Dokras, A. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.11.023 · Cited by 327
Spritzer, P. M., Lecke, S. B., Satler, F., & Morsch, D. M. (2015) · Reproduction · doi:10.1530/rep-14-0435 · Cited by 330
Cardiometabolic Aspects of the Polycystic Ovary Syndrome
Randeva, H. S., Tan, B. K., Weickert, M. O., Lois, K. B., Nestler, J. E., Sattar, N. A., & Lehnert, H. (2012) · Endocrine Reviews · doi:10.1210/er.2012-1003 · Cited by 336
Ford, E. S. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00134-5 · Cited by 315
High uric acid directly inhibits insulin signalling and induces insulin resistance
Zhu, Y., Hu, Y., Huang, T., Zhang, Y., Li, Z., Luo, C., Luo, Y., Yuan, H., Hisatome, I., Yamamoto, T., et al. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.04.080 · Cited by 312
The role of low-grade inflammation in the polycystic ovary syndrome
Repaci, A., Gambineri, A., & Pasquali, R. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.08.002 · Cited by 310
Tarkun, İ., ARSLAN, B., Cantürk, Z., Türemen, E., Şahı̇n, T., & Duman, C. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0751 · Cited by 298
Polycystic ovarian syndrome: Pathophysiology, molecular aspects and clinical implications
Diamanti-Kandarakis, E. (2008) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399408000598 · Cited by 294
Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update
Gnanadass, S. A., Prabhu, Y. D., & Gopalakrishnan, A. V. (2021) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-020-05951-2 · Cited by 305
Oxidative Stress and Polycystic Ovary Syndrome: A Brief Review
Mohammadi, M. (2019) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_576_17 · Cited by 285
Polycystic ovary syndrome current status and future perspective
Naz, R. K. (2014) · Frontiers in Bioscience-Elite · doi:10.2741/e695 · Cited by 273
Diamanti‐Kandarakis, E., Paterakis, T., Alexandraki, K., Piperi, C., Aessopos, A., Katsikis, I., Katsilambros, N. L., Kreatsas, G., & Panidis, D. (2006) · Human Reproduction · doi:10.1093/humrep/del003 · Cited by 262
Orio, F., Palomba, S., Cascella, T., Biase, S. D., Manguso, F., Tauchmanovà, L., Nardo, L. G., Labella, D., Savastano, S., Russo, T., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0628 · Cited by 257
Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome
Harborne, L., Fleming, R., Lyall, H., Norman, J. E., & Sattar, N. A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13493-9 · Cited by 262
First-Trimester C-Reactive Protein and Subsequent Gestational Diabetes
Wolf, M. S., Sandler, L., Hsu, K., Smirnakis, K. V., Ecker, J. L., & Thadhani, R. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.819 · Cited by 256
Inflammation and Human Ovarian Follicular Dynamics
Boots, C. E., & Jungheim, E. S. (2015) · Seminars in Reproductive Medicine · doi:10.1055/s-0035-1554928 · Cited by 255
Metformin Reduces Serum C-Reactive Protein Levels in Women with Polycystic Ovary Syndrome
Morin-Papunen, L. C., Rautio, K., Ruokonen, A., Hedberg, P. S. M., Puukka, M., & Tapanainen, J. S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021688 · Cited by 243
Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome
Toulis, K. A., Goulis, D. G., Mintziori, G., Kintiraki, E., Eukarpidis, E., Mouratoglou, S., Pavlaki, A., Stergianos, S., Poulasouchidou, M., Tzellos, T., et al. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmr025 · Cited by 229
González, F., Rote, N. S., Minium, J., & Kirwan, J. P. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2327 · Cited by 230
Puder, J. J., Varga, S., Kraenzlin, M., Geyter, C. D., Keller, U. B., & Müller-Stich, B. P. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1002 · Cited by 217
Savant, S. S., Sriramkumar, S., & O’Hagan, H. M. (2018) · Cancers · doi:10.3390/cancers10080251 · Cited by 215
Obesity, gestational weight gain and preterm birth: a study within the Danish National Birth Cohort
Nohr, E. A., Bech, B. H., Væth, M., Rasmussen, K. M., Henriksen, T. B., & Olsen, J. (2007) · Paediatric and Perinatal Epidemiology · doi:10.1111/j.1365-3016.2007.00762.x · Cited by 204
Escobar-Morreale, H. F., Botella-Carretero, J. I., Villuendas, G., Sancho, J., & Millán, J. L. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031365 · Cited by 199
Young Obese Women with Polycystic Ovary Syndrome Have Evidence of Early Coronary Atherosclerosis
Juran, R., Kerchner, A., Maifeld, M., van Beek, E. J. R., Jagasia, D. H., & Dokras, A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1343 · Cited by 194
Nandi, A. A., Chen, Z., Patel, R., & Poretsky, L. (2014) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.10.003 · Cited by 189
The polycystic ovary syndrome per se is not associated with increased chronic inflammation
Möhlig, M., Spranger, J., Osterhoff, M., Ristow, M., Pfeiffer, A. F. H., Schill, T., Schlößer, H. W., Brabant, G. E., & Schöfl, C. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1500525 · Cited by 180
The epithelial barrier theory and its associated diseases
Sun, N., Öğülür, İ., Mitamura, Y., Yazıcı, D., Pat, Y., Bu, X., Li, M., Zhu, X., Babayev, H., Ardıçlı, S., et al. (2024) · Allergy · doi:10.1111/all.16318 · Cited by 190
Inflammation and Glucose Intolerance
Wolf, M. S., Sauk, J. S., Shah, A., Smirnakis, K. V., Jimenez-Kimble, R., Ecker, J. L., & Thadhani, R. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.21 · Cited by 174
Ye, Z., Wang, S., Zhang, C., & Zhao, Y. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00617 · Cited by 178
Ibáñez, L., & de Zegher, F. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031281 · Cited by 172
Vryonidou, A., Papatheodorou, A., Tavridou, A., Terzi, T., Loi, V., Vatalas, I.-A., Batakis, N., Phenekos, C., & Dionyssiou-Asteriou, A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2363 · Cited by 171
Ostadmohammadi, V., Jamilian, M., Bahmani, F., & Asemi, Z. (2019) · Journal of Ovarian Research · doi:10.1186/s13048-019-0480-x · Cited by 182
Diamanti‐Kandarakis, E., Baillargeon, J., Iuorno, M. J., Jakubowicz, D. J., & Nestler, J. E. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021528 · Cited by 172
Recurrent pregnancy loss: A disease of inflammation and coagulation
Kwak-Kim, J. Y.-H., Yang, K. M., & Gilman‐Sachs, A. (2009) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2009.01079.x · Cited by 171
Inflammatory and endothelial markers in women with polycystic ovary syndrome
Diamanti‐Kandarakis, E., Alexandraki, K., Piperi, C., Protogerou, A. D., Katsikis, I., Paterakis, T., Lekakis, J., & Panidis, D. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01712.x · Cited by 168
Cardiovascular disease in the polycystic ovary syndrome: New insights and perspectives
Cussons, A. J., Stuckey, B. G. A., & Watts, G. F. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.10.007 · Cited by 165
Luque‐Ramírez, M., Mendieta-Azcona, C., Alvarez-Blasco, F., & Escobar-Morreale, H. F. (2007) · Human Reproduction · doi:10.1093/humrep/dem324 · Cited by 155
Zhao, Y., Zhang, C., Huang, Y., Yu, Y., Li, R., Li, M., Liu, N., Liu, P., & Qiao, J. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2419 · Cited by 154
Inflammatory Markers in Women with Polycystic Ovary Syndrome
Rudnicka, E., Kunicki, M., Suchta, K., Machura, P., Grymowicz, M., & Smolarczyk, R. (2020) · BioMed Research International · doi:10.1155/2020/4092470 · Cited by 155
Sun, L., Hu, W., Liu, Q., Hao, Q., Sun, B. H., Zhang, Q., Mao, S., Qiao, J., & Yan, X. (2012) · Journal of Proteome Research · doi:10.1021/pr3000317 · Cited by 155
Teede, H. J., Hutchison, S. K., Zoungas, S., & Meyer, C. (2006) · Endocrine · doi:10.1385/endo:30:1:45 · Cited by 148
Baranova, A. V., Tran, T., Birerdinc, A., & Younossi, Z. M. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04579.x · Cited by 146
Escobar-Morreale, H. F., Villuendas, G., Botella-Carretero, J. I., Sancho, J., & Millán, J. L. S. (2003) · Diabetologia · doi:10.1007/s00125-003-1090-z · Cited by 142
Banaszewska, B., Pawelczyk, L., Spaczynski, R. Z., Dziura, J., & Duleba, A. J. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1988 · Cited by 143
Samy, N., Hashim, M., Sayed, M., & Said, M. (2009) · Disease Markers · doi:10.1155/2009/465203 · Cited by 141
Sathyapalan, T., Kilpatrick, E. S., Coady, A., & Atkin, S. L. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1750 · Cited by 143
Physiopathology of polycystic ovary syndrome in endocrinology, metabolism and inflammation
Su, P., Chen, C., & Sun, Y. W. (2025) · Journal of Ovarian Research · doi:10.1186/s13048-025-01621-6 · Cited by 172
Víctor, V. M., Rocha, M., Bañuls, C., Álvarez, Á., de Pablo, C., Sánchez-Serrano, M., Gomez, M., & Hernández‐Mijares, A. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0651 · Cited by 132
Markers of insulin resistance in Polycystic ovary syndrome women: An update
Amisi, C. A. (2022) · World Journal of Diabetes · doi:10.4239/wjd.v13.i3.129 · Cited by 158
Brenjian, S., Moini, A., Yamini, N., Kashani, L., Faridmojtahedi, M., Bahramrezaie, M., Khodarahmian, M., & Amidi, F. (2020) · American Journal of Reproductive Immunology · doi:10.1111/aji.13186 · Cited by 128
Lima, P., Nivet, A., Wang, Q., Chen, Y.-A., Leader, A., Cheung, A., Tzeng, C., & Tsang, B. K. (2018) · Biology of Reproduction · doi:10.1093/biolre/ioy096 · Cited by 127
Serum aldosterone concentration and cardiovascular risk in women with polycystic ovarian syndrome
Cascella, T., Palomba, S., Tauchmanovà, L., Manguso, F., Di Biase, S., Labella, D., Giallauria, F., Vigorito, C., Colao, A., Lombardi, G., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0399 · Cited by 120
Inflammation and reproductive function in women with polycystic ovary syndrome
Vélez, L. M., Seldin, M. M., & Motta, A. B. (2021) · Biology of Reproduction · doi:10.1093/biolre/ioab050 · Cited by 135
Heutling, D., Schulz, H., Nickel, I., Kleinstein, J., Kaltwaßer, P., Westphal, S., Mittermayer, F., Wolzt, M., Krzyżanowska, K., Randeva, H. S., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0842 · Cited by 117
The importance of insulin resistance in polycystic ovary syndrome
Goodarzi, M. O., & Korenman, S. G. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(03)00734-9 · Cited by 118
Víctor, V. M., Rocha, M., Bañuls, C., Sánchez-Serrano, M., Solá, E., Gomez, M., & Hernández‐Mijares, A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0466 · Cited by 120
Caballero, A. E. (2004) · Current Diabetes Reports · doi:10.1007/s11892-004-0074-9 · Cited by 114
Indices of low-grade inflammation in polycystic ovary syndrome
DIAMANTI‐KANDARAKIS, E., PATERAKIS, T., & KANDARAKIS, H. A. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1365.015 · Cited by 112
Association Between Polycystic Ovary Syndrome and Cancer Risk
Yin, W., Falconer, H., Yin, L., Xu, L., & Ye, W. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.5188 · Cited by 112
Villuendas, G., Millán, J. L. S., Sancho, J., & Escobar-Morreale, H. F. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8309 · Cited by 116
Taponen, S., Martikainen, H. K., Järvelin, M., Sovio, U., Laitinen, J. H., Pouta, A. M., Hartikainen, A., McCarthy, M. I., Franks, S., Paldanius, M., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031720 · Cited by 111
Cardiovascular risk in women with polycystic ovarian syndrome (PCOS)
Bickerton, A. S. T., Clark, N. M., Meeking, D. R., Shaw, K. M., Crook, M. A., Lumb, P. J., Turner, C., & Cummings, M. H. (2005) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.015271 · Cited by 108
Ibáñez, L., & de Zegher, F. (2006) · Human Reproduction Update · doi:10.1093/humupd/dmi054 · Cited by 109
Puurunen, J., Piltonen, T., Morin-Papunen, L., Perheentupa, A., Järvelä, I., Ruokonen, A., & Tapanainen, J. S. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0039 · Cited by 108
Effects of Simvastatin and Metformin on Polycystic Ovary Syndrome after Six Months of Treatment
Banaszewska, B., Pawelczyk, L. A., Spaczyński, R., & Dulęba, A. J. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0501 · Cited by 110
González, F., Sia, C. L., Shepard, M. K., Rote, N. S., & Minium, J. (2012) · Human Reproduction · doi:10.1093/humrep/des320 · Cited by 107
Duică, F., Dănilă, C. A., Boboc, A. E., Antoniadis, P., Condrat, C. E., Onciul, S., Suciu, N., Creţoiu, S. M., Varlas, V. N., & Crețoiu, D. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.614679 · Cited by 110
Heart Rate Variability in Young Women with Polycystic Ovary Syndrome
Yı́ldı́rı́r, A., Aybar, F., Kabakçı, G., Yaralı́, H., & Oto, A. (2006) · Annals of Noninvasive Electrocardiology · doi:10.1111/j.1542-474x.2006.00122.x · Cited by 105
Mediators of Inflammation in Polycystic Ovary Syndrome in Relation to Adiposity
Sathyapalan, T., & Atkin, S. L. (2010) · Mediators of Inflammation · doi:10.1155/2010/758656 · Cited by 104
Cobin, R. H., Futterweit, W., Nestler, J. E., Reaven, G. M., Jellinger, P. S., Handelsman, Y., Redmond, G. P., & Thatcher, S. S. (2005) · Endocrine Practice · doi:10.4158/ep.11.2.125 · Cited by 105
The latest reports and treatment methods on polycystic ovary syndrome
Stańczak, N. A., Grywalska, E., & Dudzińska, E. (2024) · Annals of Medicine · doi:10.1080/07853890.2024.2357737 · Cited by 161
The Role of Obesity in the Development of Polycystic Ovary Syndrome
Motta, A. B. (2012) · Current Pharmaceutical Design · doi:10.2174/13816128112092482 · Cited by 104
Interleukin-6 Levels in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
Peng, Z., Sun, Y., Lv, X., Zhang, H., Liu, C., & Dai, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148531 · Cited by 102
The inflammatory markers in polycystic ovary syndrome: association with obesity and IVF outcomes
Çakıroğlu, Y., Vural, F., & Vural, B. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0446-4 · Cited by 101
Talbott, E. O., Zborowski, J. V., Boudreaux, M. Y., McHugh-Pemu, K. P., Sutton-Tyrrell, K., & Guzick, D. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032110 · Cited by 98
Peral, B., Millán, J. L. S., Castello, R., Moghetti, P., & Escobar-Morreale, H. F. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.8.8715 · Cited by 99
Chakraborty, P., Ghosh, S., Goswami, S. K., Kabir, S. N., Chakravarty, B., & Jana, K. (2013) · Biological Trace Element Research · doi:10.1007/s12011-012-9592-5 · Cited by 99
Association of Polymorphisms in the Interleukin 6 Receptor Complex with Obesity and Hyperandrogenism
Escobar-Morreale, H. F., Calvo, R. M., Villuendas, G., Sancho, J., & Millán, J. L. S. (2003) · Obesity Research · doi:10.1038/oby.2003.136 · Cited by 97
González, F., Minium, J., Rote, N. S., & Kirwan, J. P. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0694 · Cited by 98
Metabolic profiling of polycystic ovary syndrome reveals interactions with abdominal obesity
Alves, A. C., Valcarcel, B., Mäkinen, V.-P., Morin-Papunen, L. C., Sebert, S. P., Kangas, A. J., Soininen, P., Das, S., Iorio, M. D., Coin, L., et al. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.126 · Cited by 99
Ibáñez, L., Jaramillo, A. M. A., Ferrer, A., & de Zegher, F. (2005) · Human Reproduction · doi:10.1093/humrep/dei072 · Cited by 94
Coagulation and Fibrinolytic Disturbances in Women with Polycystic Ovary Syndrome
Mannerås-Holm, L., Baghaei, F., Holm, G., Janson, P. O., Ohlsson, C., Lönn, M., & Stener‐Victorin, E. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2279 · Cited by 93
Popovic, M., Sartorius, G. A., & Christ‐Crain, M. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-019-00737-4 · Cited by 94
Adipose tissue and reproduction in women
BOHLER, H. C. L., Mokshagundam, S. L., & Winters, S. J. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.03.079 · Cited by 96
Kurt, R. K., Okyay, A. G., Hakverdi, A. U., Güngören, A., Dolapçıoğlu, K., Karateke, A., & Dogan, M. O. (2014) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-014-3199-3 · Cited by 91
Cirillo, F., Catellani, C., Lazzeroni, P., Sartori, C., Nicoli, A., Amarri, S., Sala, G. B. L., & Street, M. E. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00879 · Cited by 90
Menstrual irregularity and asthma and lung function
Real, F. G., Svanes, C., Omenaas, E. R., Antó, J. M., Plana, E., Janson, C., Jarvis, D., Zemp, E., Wjst, M., Leynaert, B., et al. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.04.041 · Cited by 91
Metadata
- Authors
- Kelly, C. C. J., Lyall, H., Petrie, J. R., Gould, G. W., Connell, J. M. C., & Sattar, N.
- Affiliations
- University of Glasgow (GB)
- Corresponding author
- Sattar, Naveed
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2001-06
- Volume
- 86
- Issue
- 6
- Pages
- 2453-2455
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2168847507
- Cited by
- 640
- References
- 26
- Citations by year
- 2026: 22 · 2025: 26 · 2024: 21 · 2023: 32 · 2022: 25 · 2021: 41 · 2020: 28 · 2019: 22 · 2018: 20 · 2017: 19 · 2016: 20 · 2015: 19 · 2014: 28 · 2013: 21 · 2012: 35
- FWCI
- 18.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- polycystic ovary syndrome, low-grade inflammation, C-reactive protein, insulin resistance, coronary heart disease risk, type 2 diabetes risk, body mass index, hyperinsulinemic-euglycemic clamp, testosterone, women
- MeSH terms
- Adult, C-Reactive Protein, Chronic Disease, Female, Humans, Inflammation, Insulin Resistance, Osmolar Concentration, Polycystic Ovary Syndrome, Reference Values, Sex Hormone-Binding Globulin, Testosterone, Body Mass Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review